This is a second revision to a competing renewal for 5 years of funding to extend a research program entitled """"""""MRI/MRSI Studies of Bipolar Treatment Response."""""""" The original application was funded for a 3-year period and the project was conducted both at Harvard/McLean Hospital and the University of Washington. Major findings during the prior period of funding include (1) observation of a diffuse pattern of neurochemical change consistent with mitochondrial dysfunction (increased gray matter lactate and glutamate/glutamine/GABA (Glx)) in untreated patients with bipolar disorder; (2) measured changes toward normal values in brain Glx were associated with lithium treatment, but not valproic acid therapy; and (3) neuroanatomic alterations identified using voxel based morphometry and shape analyses were associated with a bipolar disorder diagnosis. This revised application is focused on the role that mitochondrial dysfunction plays in bipolar disorder. In addition to our prior MRSI findings, recent, independent, post-mortem data suggests that """"""""pronounced and extensive decrease in the expression of genes regulating oxidative phosphorylation"""""""" is present in brain tissue from individuals with bipolar disorder (Konradi et al., 2004). To support the hypothesis that these energetic abnormalities may create a novel therapeutic target for the treatment of bipolar disorder, extensive new preliminary data on the effects of cytidine on mood and brain chemistry is provided. Clinically, cytidine was more effective than placebo in improving the symptoms of bipolar depression when added to divalproex. Intriguingly, in contrast to the effects of lithium, cytidine appears to reduce both Glx and brain lactate levels. All studies proposed in this revised application will be performed at the McLean Hospital Brain Imaging Center. Studying in total of 130 subjects with bipolar disorder and 60 healthy comparison subjects, 3 specific lines of research will be pursued. Specific projects are designed to (1) further characterize changes in brain chemistry related to altered mitochondrial function in bipolar disorder using multinuclear (phosphorus-31 and hydrogen-1) magnetic resonance spectroscopic imaging at high-field; (2) evaluate the therapeutic efficacy and the neurochemical effects of uridine, a neurochemical to which cytidine is converted in man, compared to paroxetine in lithium treated bipolar subjects; and (3) utilize novel morphometric methods to better understand neuroanatomic correlates of disease manifestation and treatment effects.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BDCN-A (02))
Program Officer
Rumsey, Judith M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Schools of Medicine
Salt Lake City
United States
Zip Code
Aydin, Burç; Yurt, Ay?egül; Gökmen, Necati et al. (2016) Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study. J Affect Disord 206:315-320
Yildiz, Ay?egül; Aydin, Burç; Gökmen, Necati et al. (2016) Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study. Biol Psychiatry Cogn Neurosci Neuroimaging 1:125-131
Shi, Xian-Feng; Carlson, Paul J; Sung, Young-Hoon et al. (2015) Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study. Bipolar Disord 17:743-52
Plante, David T; Trksak, George H; Jensen, J Eric et al. (2014) Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla. Sleep 37:1919-27
Shi, Xian-Feng; Carlson, Paul J; Kim, Tae-Suk et al. (2014) Effect of altitude on brain intracellular pH and inorganic phosphate levels. Psychiatry Res 222:149-56
Harper, David G; Jensen, J Eric; Ravichandran, Caitlin et al. (2014) Tissue-specific differences in brain phosphodiesters in late-life major depression. Am J Geriatr Psychiatry 22:499-509
Harper, David G; Plante, David T; Jensen, J Eric et al. (2013) Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla. Sleep 36:493-500
Brennan, Brian P; Jensen, John Eric; Hudson, James I et al. (2013) A placebo-controlled trial of acetyl-L-carnitine and ?-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol 33:627-35
Allen, Patricia J; D'Anci, Kristen E; Kanarek, Robin B et al. (2012) Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats. Pharmacol Biochem Behav 101:588-601
Lyoo, In Kyoon; Yoon, Sujung; Kim, Tae-Suk et al. (2012) A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. Am J Psychiatry 169:937-945

Showing the most recent 10 out of 48 publications